Table 3 Haematological parameters after oral administration of P. copri for 29 days.

From: Evaluation of hypoglycemic effect, safety and immunomodulation of Prevotella copri in mice

Blood cell parameter

Control

Pasteurized

Live

WBC (109/L)

4.098 ± 0.596

4.497 ± 0.494

4.880 ± 0.666

LYM (109/L)

3.301 ± 0,543

3.762 ± 0.410

4.373 ± 0.603

MON (109/L)

0.313 ± 0.080

0.330 ± 0.067

0.294 ± 0.063

NEU (109/L)

0.483 ± 0.127

0.403 ± 0.091

0.214 ± 0.073

MCH (pg)

14.280 ± 0.315

14.250 ± 0.119

14.480 ± 0.111

MCHC (g/dL)

32.500 ± 0.764

33.510 ± 0.254

33.410 ± 0.206

RDWs (fl)

33.290 ± 0.522

32.040 ± 0.302

32.590 ± 0.502

RDWc % (%)

17.420 ± 0.214

17.370 ± 0.157

17.360 ± 0.200

PLT (109/L)

429.100 ± 26.429

447.900 ± 57.510

486.800 ± 40.908

PCT % (%)

0.233 ± 0.016

0.245 ± 0.033

0.263 ± 0.022

MPV (fl)

5.450 ± 0.083

5.460 ± 0.070

5.390 ± 0.069

PDWs (fl)

5.650 ± 0.099

5.830 ± 0.176

5.820 ± 0.184

PDWc % (%)

27.800 ± 0.257

28.230 ± 0.404

28.180 ± 0.419

  1. Values are presented as mean ± SEM (n = 10).
  2. No mean values were significantly different from the control group (p < 0.05).
  3. WBC white blood cell count, LYM lymphocytes, MON monocytes, NEU neutrophils, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, RDWs red cell distribution width—SD, RDWc red cell distribution width—CV, PLT platelet count, PCT thrombocrit, MPV mean platelet volume, PDWs platelet distribution width—SV, PDWc platelet distribution width—CV.
Back to article page